|
Name |
Octadecanoic acid, 2-[(trimethylsilyl)oxy]-, methyl ester
|
Molecular Formula | C22H46O3Si | |
IUPAC Name* |
methyl 2-trimethylsilyloxyoctadecanoate
|
|
SMILES |
CCCCCCCCCCCCCCCCC(C(=O)OC)O[Si](C)(C)C
|
|
InChI |
InChI=1S/C22H46O3Si/c1-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21(22(23)24-2)25-26(3,4)5/h21H,6-20H2,1-5H3
|
|
InChIKey |
MPVPFICBAYSSLQ-UHFFFAOYSA-N
|
|
Synonyms |
Octadecanoic acid, 2-[(trimethylsilyl)oxy]-, methyl ester; 56196-58-8; Methylstearate, 2-trimethylsiloxy; 2-(Trimethylsilyloxy)stearic acid methyl ester; DTXSID301346993; Methyl stearate, 2-trimethylsiloxy; methyl trimethylsiloxy octadecanoate; Methyl 2-hydroxystearate, TMS derivative; Methyl 2-[(trimethylsilyl)oxy]octadecanoate; METHYL 2-TRIMETHYLSILOXYOCTADECANOATE; Methyl 2-[(trimethylsilyl)oxy]octadecanoate #; .alpha.-Hydroxystearic acid, O-TMS, methyl ester; Octadecanoic acid, 2-hydroxy, methyl ester, O-TMS
|
|
CAS | 56196-58-8 | |
PubChem CID | 524479 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 386.7 | ALogp: | 7.3 |
HBD: | 0 | HBA: | 3 |
Rotatable Bonds: | 19 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 35.5 | Aromatic Rings: | 0 |
Heavy Atoms: | 26 | QED Weighted: | 0.141 |
Caco-2 Permeability: | -4.777 | MDCK Permeability: | 0.00001510 |
Pgp-inhibitor: | 0.171 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.004 | 20% Bioavailability (F20%): | 0.997 |
30% Bioavailability (F30%): | 0.997 |
Blood-Brain-Barrier Penetration (BBB): | 0.008 | Plasma Protein Binding (PPB): | 100.15% |
Volume Distribution (VD): | 2.603 | Fu: | 0.53% |
CYP1A2-inhibitor: | 0.218 | CYP1A2-substrate: | 0.568 |
CYP2C19-inhibitor: | 0.479 | CYP2C19-substrate: | 0.832 |
CYP2C9-inhibitor: | 0.206 | CYP2C9-substrate: | 0.949 |
CYP2D6-inhibitor: | 0.135 | CYP2D6-substrate: | 0.099 |
CYP3A4-inhibitor: | 0.346 | CYP3A4-substrate: | 0.072 |
Clearance (CL): | 3.356 | Half-life (T1/2): | 0.047 |
hERG Blockers: | 0.331 | Human Hepatotoxicity (H-HT): | 0.069 |
Drug-inuced Liver Injury (DILI): | 0.237 | AMES Toxicity: | 0.01 |
Rat Oral Acute Toxicity: | 0.006 | Maximum Recommended Daily Dose: | 0.017 |
Skin Sensitization: | 0.963 | Carcinogencity: | 0.03 |
Eye Corrosion: | 0.995 | Eye Irritation: | 0.972 |
Respiratory Toxicity: | 0.948 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001200 | 0.718 | D07ILQ | 0.517 | ||||
ENC000496 | 0.654 | D00FGR | 0.515 | ||||
ENC000488 | 0.636 | D0Z5SM | 0.465 | ||||
ENC001217 | 0.634 | D00AOJ | 0.463 | ||||
ENC000280 | 0.630 | D0T9TJ | 0.405 | ||||
ENC000271 | 0.615 | D05ATI | 0.400 | ||||
ENC000424 | 0.613 | D0O1PH | 0.394 | ||||
ENC000497 | 0.607 | D0P1RL | 0.362 | ||||
ENC000489 | 0.597 | D00MLW | 0.345 | ||||
ENC000356 | 0.595 | D00STJ | 0.338 |